Literature DB >> 10048719

ESR study of plasmatic membrane of the transplantable melanoma cells in relation to their biological properties.

K Kozłowska1, J Nowak, B Kwiatkowski, M Cichorek.   

Abstract

Using the spin labelling method we studied changes in the structure and dynamics of molecular mobility in the plasmatic membrane accompanied by a spontaneous alteration of a melanotic melanoma line into an amelanotic form with a higher growth rate, changed antigenicity and immunogenicity. The calculated ratio of the low-field line (A) intensity to the central line (C) intensity of the spectrum showed statistically significant differences in the order of parameters in the plasmatic membranes of both forms of melanocytes. The significantly broader central line (deltaW0) in the spectra of labelled amelanotic melanoma cells than in the original cell line indicated changes in the membrane structure leading to a lowering of the degree of order in the phospholipid bilayer. It has been suggested that a progression of transplantable melanomas is accompanied by an increase in membrane fluidity and reduction in molecular mobility dynamics within it.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048719     DOI: 10.1016/S0940-2993(99)80074-8

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  8 in total

Review 1.  Studies on anticancer activities of antimicrobial peptides.

Authors:  David W Hoskin; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2007-11-22

2.  Antitumor activity of recombinant antimicrobial peptide penaeidin-2 against kidney cancer cells.

Authors:  Ming-Xiang Meng; Jian-Fang Ning; Jing-You Yu; Dan-Dan Chen; Xiao-Lin Meng; Jin-Ping Xu; Jie Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

3.  Infrared Spectroscopic Study of Multi-Component Lipid Systems: A Closer Approximation to Biological Membrane Fluidity.

Authors:  Maria C Klaiss-Luna; Marcela Manrique-Moreno
Journal:  Membranes (Basel)       Date:  2022-05-20

4.  Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.

Authors:  Ketil André Camilio; Gerd Berge; Chandra Sekhar Ravuri; Oystein Rekdal; Baldur Sveinbjørnsson
Journal:  Cancer Immunol Immunother       Date:  2014-03-28       Impact factor: 6.968

5.  Identification of a novel lytic peptide for the treatment of solid tumours.

Authors:  Rolf Bjerkvig; Lars Prestegarden; Claudia Szczepanski; Olav Tenstad; Anne Baumann; Aurora Martinez; Reidar Myklebust
Journal:  Genes Cancer       Date:  2014-05

Review 6.  Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review).

Authors:  Wararat Chiangjong; Somchai Chutipongtanate; Suradej Hongeng
Journal:  Int J Oncol       Date:  2020-07-10       Impact factor: 5.650

Review 7.  From antimicrobial to anticancer peptides. A review.

Authors:  Diana Gaspar; A Salomé Veiga; Miguel A R B Castanho
Journal:  Front Microbiol       Date:  2013-10-01       Impact factor: 5.640

Review 8.  Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.

Authors:  Martyna Śniegocka; Ewa Podgórska; Przemysław M Płonka; Martyna Elas; Bożena Romanowska-Dixon; Małgorzata Szczygieł; Michał A Żmijewski; Mirosława Cichorek; Anna Markiewicz; Anna A Brożyna; Andrzej T Słominski; Krystyna Urbańska
Journal:  Int J Mol Sci       Date:  2018-04-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.